Saved source record
Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.
This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Animal
- Published
- 2026-07-14
- Authors
- Yang Q, Zhang Y, Liu P, Yan Z, Li C, Tang Y, Yang Q.
- Journal or registry
- Not reported
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- National Natural Science Foundation of China; Scientific and Technological Research Program of Chongqing Municipal Education Commission; Sichuan Medical and Health Care Promotion Institute Scientific Research Project; Graduate Innovation Project of the First Affiliated Hospital of Chongqing Medical University
- Identifiers
- DOI: 10.1007/s11064-026-04846-z · PMID: 42443448
- First found
- Sep 25, 2026
- Last found
- Sep 25, 2026
Original sources
Browse saved studies · Search live sources